Marker Therapeutics Inc (MRKR) — Capital Reinvestment Ratio

Latest as of September 2024: 0.00x

Marker Therapeutics Inc (MRKR) has a Capital Reinvestment Ratio of 0.00x as of September 2024, meaning it reinvests 0% of its operating cash flow ($1.20 Million) in capital expenditures ($1.00). See Marker Therapeutics Inc balance sheet independence to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$1.20 Million

USD

Capital Expenditures

$1.00

USD

Data as of

Sep 2024

Most recent filing

Annual Capital Reinvestment Ratio for Marker Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Marker Therapeutics Inc from None to None. For live market cap and broader valuation context, see Marker Therapeutics Inc stock valuation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow